Medicinal products have so far been assessed primarily in terms of efficacy, safety and cost-effectiveness. A feasibility study shows how environmental information can also be systematically incorporated into the decision-making process. An ‘Environmental Pharmaceutical Index’ for Germany aims to provide standardised environmental information on active pharmaceutical ingredients and make it accessible for use in clinical practice.
EU pesticide regulation needs to assess environmental and health risks in a way that reflects real-world conditions. Two new SPRINT policy briefs highlight the need for action: before authorisation, greater consideration should be given to mixtures, environmental fate, exposure pathways and sensitive species. After authorisation, more comprehensive monitoring and closer integration with regulatory decision-making are needed.
Geopolitical tensions and volatile energy markets are bringing Europe’s competitiveness into sharper focus. An Ariadne background paper shows how climate policy, investment certainty and industrial transformation need to work together. It focuses on governance, financing, the EU Emissions Trading System and energy infrastructure for a resilient, climate-neutral economy.
Climate-driven changes in fish stocks are posing challenges for fisheries management in the North-East Atlantic. A policy brief from the Marine SABRES project shows how more flexible quotas, international cooperation, and climate and ecosystem data can make pelagic fisheries more resilient. It considers ecological, economic and social aspects together.
The EU Nature Restoration Regulation aims to restore degraded ecosystems across Europe. An article in Nature Reviews Biodiversity shows why spatially coordinated ‘restoration landscapes’ are needed to achieve this. Effective governance, long-term funding and the involvement of landowners, public authorities and other stakeholders are key.
